{"DataElement":{"publicId":"6943655","version":"1","preferredName":"CTCAE Grade 3 CTCAE Grade 4 CTCAE Grade 5 Potential Immune-Mediated Adverse Reaction Occurrence Type","preferredDefinition":"A description of the potential immune-mediated adverse reaction that occurred that was severe, life threatening, disabling or fatal.","longName":"6943597v1.0:6943624v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"6943597","version":"1","preferredName":"CTCAE Grade 3 CTCAE Grade 4 CTCAE Grade 5 Potential Immune-Mediated Adverse Reaction Occurrence","preferredDefinition":"An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities._Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death._The termination of life associated with an adverse event._The likelihood or possibility that a specific state or condition will exist or that an action will occur._An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system._An instance of something happening, such as an event or incident.","longName":"6973739v1.0:2234856v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"6973739","version":"1","preferredName":"Severe Adverse Event Life Threatening or Disabling Adverse Event Death Related to Adverse Event Potential Immune-Mediated Adverse Reaction","preferredDefinition":"An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities.:Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.:The termination of life associated with an adverse event.:The likelihood or possibility that a specific state or condition will exist or that an action will occur.:An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system.","longName":"6973739v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Severe Adverse Event","conceptCode":"C41340","definition":"An adverse event experience that requires intensive therapeutic intervention and interrupts usual daily activities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Life Threatening or Disabling Adverse Event","conceptCode":"C41337","definition":"Any adverse event that places the patient, in the view of the initial reporter, at immediate risk of death from the adverse event as it occurred, i.e., it does not include an adverse experience that, had it occurred in a more severe form, might have caused death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Death Related to Adverse Event","conceptCode":"C48275","definition":"The termination of life associated with an adverse event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Potential","conceptCode":"C62230","definition":"The likelihood or possibility that a specific state or condition will exist or that an action will occur.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Immune-Mediated Adverse Reaction","conceptCode":"C131137","definition":"An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"94665533-57A4-4A4E-E053-F662850A1B5E","latestVersionIndicator":"Yes","beginDate":"2019-10-08","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-10-08","modifiedBy":"ONEDATA","dateModified":"2019-10-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2234856","version":"1","preferredName":"Occurrence","preferredDefinition":"Occurrence; an instance of something happening.","longName":"C25275","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9860F29-72B8-7421-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-14","modifiedBy":"ONEDATA","dateModified":"2005-06-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9350CE66-9532-7E91-E053-F662850A451D","latestVersionIndicator":"Yes","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6943624","version":"1","preferredName":"Immune-Mediated Adverse Reaction Type","preferredDefinition":"An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system._Something distinguishable as an identifiable class based on common qualities.","longName":"6943624v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Dermatitis / rash","valueDescription":"Dermatitis And/Or Skin Rash Disease or Disorder","ValueMeaning":{"publicId":"6943625","version":"1","preferredName":"Dermatitis And/Or Skin Rash Disease or Disorder","longName":"6943625","preferredDefinition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.: Used to indicate that either or both of two items or options may be valid.: Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dermatitis","conceptCode":"C2983","definition":"An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"934E1FC3-9ED1-0FD6-E053-F662850AB7A8","latestVersionIndicator":"Yes","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9EEA-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Encephalitis","valueDescription":"Encephalitis","ValueMeaning":{"publicId":"3211040","version":"1","preferredName":"Encephalitis","longName":"3211040","preferredDefinition":"An acute inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Encephalitis","conceptCode":"C26760","definition":"An inflammatory process affecting the brain parenchyma. Causes include viral infections and less frequently bacterial infections, toxins, and immune-mediated processes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-C554-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9EF4-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Polyneuropathy","valueDescription":"Polyneuropathy","ValueMeaning":{"publicId":"6776308","version":"1","preferredName":"Polyneuropathy","longName":"6776308","preferredDefinition":"A disease or disorder affecting more than one nerve.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polyneuropathy","conceptCode":"C26951","definition":"A disease or disorder affecting more than one nerve.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8AC02B9E-C609-1395-E053-F662850A12A8","latestVersionIndicator":"Yes","beginDate":"2019-06-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-06-07","modifiedBy":"ONEDATA","dateModified":"2019-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9EFF-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Myocarditis","valueDescription":"Myocarditis","ValueMeaning":{"publicId":"2946008","version":"1","preferredName":"Myocarditis","longName":"2946008","preferredDefinition":"Inflammation of the muscle tissue of the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocarditis","conceptCode":"C34831","definition":"Inflammation of the muscle tissue of the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746944AF-42A3-DCDB-E040-BB89AD437B02","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9F0A-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Myositis","valueDescription":"Myositis","ValueMeaning":{"publicId":"2562650","version":"1","preferredName":"Myositis","longName":"2562650","preferredDefinition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myositis","conceptCode":"C27578","definition":"An inflammatory process affecting the skeletal muscles. Causes include infections, injuries, and autoimmune disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-C1C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-10-11","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-11","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9F14-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Autoimmune hepatitis","valueDescription":"Autoimmune Hepatitis","ValueMeaning":{"publicId":"3210889","version":"1","preferredName":"Autoimmune Hepatitis","longName":"3210889","preferredDefinition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Autoimmune Hepatitis","conceptCode":"C27029","definition":"Hepatitis caused by autoantibodies. Drugs, infections, and toxins may trigger the production of the autoantibodies against the liver parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-B01E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9F1E-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Autoimmune thyroiditis","valueDescription":"Hashimoto Thyroiditis","ValueMeaning":{"publicId":"3211123","version":"1","preferredName":"Hashimoto Thyroiditis","longName":"3211123","preferredDefinition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hashimoto Thyroiditis","conceptCode":"C27191","definition":"An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-D10E-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9F33-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Polymyositis","valueDescription":"Polymyositis","ValueMeaning":{"publicId":"2585215","version":"1","preferredName":"Polymyositis","longName":"2585215","preferredDefinition":"Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY, NERVOUS SYSTEM); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Polymyositis","conceptCode":"C26925","definition":"An idiopathic inflammatory disorder affecting the muscles. It presents with symmetrical proximal muscle weakness and elevated skeletal muscle enzymes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2687D788-9C0F-74B4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-01-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2007-01-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"934E1FC3-9F3E-0FD6-E053-F662850AB7A8","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","deletedIndicator":"No"},{"value":"Pneumonitis / Interstitial lung disease","valueDescription":"Pneumonitis And/Or Interstitial Lung Disease Disease or Disorder","ValueMeaning":{"publicId":"6944191","version":"1","preferredName":"Pneumonitis And/Or Interstitial Lung Disease Disease or Disorder","longName":"6944191","preferredDefinition":"An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.: Used to indicate that either or both of two items or options may be valid.: A category of lung diseases characterized by varying degrees of inflammation and fibrosis of the interstitial lung tissue. Causes include occupational lung exposures and drugs. In a minority of cases there is no clear cause and such cases are termed idiopathic interstitial pneumonia.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pneumonitis","conceptCode":"C113159","definition":"An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Interstitial Lung Disease","conceptCode":"C164315","definition":"A category of lung diseases characterized by varying degrees of inflammation and fibrosis of the interstitial lung tissue. Causes include occupational lung exposures and drugs. In a minority of cases there is no clear cause and such cases are termed idiopathic interstitial pneumonia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"93628F78-DE64-1942-E053-F662850A7C3E","latestVersionIndicator":"Yes","beginDate":"2019-09-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-25","modifiedBy":"ONEDATA","dateModified":"2019-09-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"93628F78-DE7D-1942-E053-F662850A7C3E","beginDate":"2019-09-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-25","modifiedBy":"ONEDATA","dateModified":"2019-09-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6943623","version":"1","preferredName":"Immune-Mediated Adverse Reaction Type","preferredDefinition":"An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system.:Something distinguishable as an identifiable class based on common qualities.","longName":"C131137:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immune-Mediated Adverse Reaction","conceptCode":"C131137","definition":"An adverse event resulting from an immune system reaction to a drug or device. It can affect any organ or system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"934E1FC3-9EA5-0FD6-E053-F662850AB7A8","latestVersionIndicator":"Yes","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"ONEDATA","dateModified":"2019-09-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"934E1FC3-9EB6-0FD6-E053-F662850AB7A8","latestVersionIndicator":"Yes","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"What was the severe adverse e","type":"Preferred Question Text","description":"What was the severe adverse event, life threatening or disabling adverse event or death related to adverse event potential immune-mediated adverse reaction that occurred?","url":null,"context":"NHLBI"},{"name":"Specify grade >= 3 potentially immune-mediated complications of interest","type":"Application Standard Question Text","description":"Specify grade >= 3 potentially immune-mediated complications of interest","url":null,"context":"NHLBI"},{"name":"Specify grade >= 3 potentially immune-mediated complications of interest","type":"Alternate Question Text","description":"Specify grade >= 3 potentially immune-mediated complications of interest","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"93516322-B27B-2BED-E053-F662850AEC8E","latestVersionIndicator":"Yes","beginDate":"2019-09-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2019-09-24","modifiedBy":"KUMMEROA","dateModified":"2020-01-30","changeDescription":". System generated def displayed as alt def.; System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}